Upgrade for Complete Access See Plans and Pricing

Serving leading biopharmaceutical companies globally:

McKesson
Johnson and Johnson
Express Scripts
Baxter
Mallinckrodt
McKinsey

Last Updated: November 28, 2021

DrugPatentWatch Database Preview

New River Company Profile


Email this page to a colleague

« Back to Dashboard

What is the competitive landscape for NEW RIVER, and what generic and branded alternatives to NEW RIVER drugs are available?

NEW RIVER has three approved drugs.



Summary for New River
US Patents:0
Tradenames:7
Ingredients:3
NDAs:3

Drugs and US Patents for New River

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
New River DOXEPIN HYDROCHLORIDE doxepin hydrochloride CAPSULE;ORAL 016987-006 Approved Prior to Jan 1, 1982 DISCN No No ⤷  Free Forever Trial ⤷  Free Forever Trial
New River TRIAVIL 2-10 amitriptyline hydrochloride; perphenazine TABLET;ORAL 014715-004 Approved Prior to Jan 1, 1982 DISCN No No ⤷  Free Forever Trial ⤷  Free Forever Trial
New River DOXEPIN HYDROCHLORIDE doxepin hydrochloride CAPSULE;ORAL 016987-003 Approved Prior to Jan 1, 1982 DISCN No No ⤷  Free Forever Trial ⤷  Free Forever Trial
New River TRIAVIL 4-10 amitriptyline hydrochloride; perphenazine TABLET;ORAL 014715-003 Approved Prior to Jan 1, 1982 DISCN No No ⤷  Free Forever Trial ⤷  Free Forever Trial
New River TRIAVIL 2-25 amitriptyline hydrochloride; perphenazine TABLET;ORAL 014715-002 Approved Prior to Jan 1, 1982 DISCN No No ⤷  Free Forever Trial ⤷  Free Forever Trial
New River PROFERDEX ferric oxyhydroxide INJECTABLE;INJECTION 017807-001 Approved Prior to Jan 1, 1982 DISCN No No ⤷  Free Forever Trial ⤷  Free Forever Trial
New River TRIAVIL 4-25 amitriptyline hydrochloride; perphenazine TABLET;ORAL 014715-005 Approved Prior to Jan 1, 1982 DISCN No No ⤷  Free Forever Trial ⤷  Free Forever Trial
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Expired US Patents for New River

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
New River DOXEPIN HYDROCHLORIDE doxepin hydrochloride CAPSULE;ORAL 016987-001 Approved Prior to Jan 1, 1982 3,420,851 ⤷  Free Forever Trial
New River DOXEPIN HYDROCHLORIDE doxepin hydrochloride CAPSULE;ORAL 016987-006 Approved Prior to Jan 1, 1982 3,420,851 ⤷  Free Forever Trial
New River DOXEPIN HYDROCHLORIDE doxepin hydrochloride CAPSULE;ORAL 016987-004 Approved Prior to Jan 1, 1982 3,420,851 ⤷  Free Forever Trial
New River TRIAVIL 4-25 amitriptyline hydrochloride; perphenazine TABLET;ORAL 014715-005 Approved Prior to Jan 1, 1982 3,428,735 ⤷  Free Forever Trial
New River TRIAVIL 4-10 amitriptyline hydrochloride; perphenazine TABLET;ORAL 014715-003 Approved Prior to Jan 1, 1982 3,428,735 ⤷  Free Forever Trial
New River TRIAVIL 4-50 amitriptyline hydrochloride; perphenazine TABLET;ORAL 014715-006 Approved Prior to Jan 1, 1982 3,428,735 ⤷  Free Forever Trial
New River TRIAVIL 2-25 amitriptyline hydrochloride; perphenazine TABLET;ORAL 014715-002 Approved Prior to Jan 1, 1982 3,428,735 ⤷  Free Forever Trial
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >Patent No. >Patent Expiration
Similar Applicant Names
Applicants may be listed under multiple names.
Here is a list of applicants with similar names.

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Colorcon
Moodys
Baxter
Boehringer Ingelheim
Mallinckrodt
Express Scripts

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.